Andrea Chiacchio

Jun 27, 2024 | mdpi.com | Francesco D’Ambrosio |Mario Caggiano |Andrea Chiacchio |Francesco Giordano

All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.

Jun 5, 2023 | mdpi.com | Francesco D’Ambrosio |Alessandra Amato |Laura Sisalli |Andrea Chiacchio

4.2. The Influence of Most Important Systemic Diseases and Drugs Evaluated on the Outcomes Considered in This Umbrella Review 4.2.1. Metabolic Bone DiseaseMetabolic bone diseases, such as osteopenia and osteoporosis, are pathologies particularly frequent in the elderly population. Osteoporosis affects more than 200 million individuals worldwide, mainly postmenopausal women. Osteoporosis is a disease that leads to a progressive loss of bone mass, increasing the risk of fractures and bone fragility.